Tresiba FlexTouch is a injection pharmaceutical product marketed by Novo Nordisk containing Insulin degludec — available as 100 U/mL or 200 U/mL depending on the pen, available for wholesale and bulk purchase on PharmaBag.
Contains insulin degludec, a long-acting insulin used for blood glucose control in diabetes. It provides prolonged insulin action and is administered using a pre-filled pen.
| Product Name | Tresiba FlexTouch |
|---|---|
| Salt Composition | Insulin degludec — available as 100 U/mL or 200 U/mL depending on the pen |
| Manufacturer / Marketer | Novo Nordisk |
| Dosage Form | Injection |
| Product Category | Ethical |
Prices are wholesale rates offered by verified suppliers and exclude GST unless stated. Product information is provided for trade reference only and is not medical advice. Always verify the pack, batch and prescribing information before dispensing.
Tresiba FlexTouch contains Insulin degludec — available as 100 U/mL or 200 U/mL depending on the pen. Always confirm the composition and strength against the product pack and the prescribing information before dispensing.
Tresiba FlexTouch is marketed by Novo Nordisk. PharmaBag sources it through verified wholesale suppliers who hold valid drug licences.
Yes. PharmaBag is a B2B wholesale platform serving retail pharmacies, hospitals, clinics and distributors across India. Buyers complete a one-time verification with a drug licence and GST or PAN details, after which Tresiba FlexTouch can be ordered in bulk with a GST invoice and pan-India delivery.
Yes. Every order placed on PharmaBag, including Tresiba FlexTouch, is billed with a GST invoice from the supplying wholesaler at the applicable GST rate.